Off-label useSee our Spironolactone safety rating →

Spironolactone for acne (hormonal, in women)

Spironolactone is a decades-old, inexpensive potassium-sparing water pill that the FDA approved for high blood pressure and heart failure. Dermatologists prescribe it off-label for hormonal acne in adult women, where it acts as an anti-androgen - blunting the testosterone-driven oil production behind stubborn jawline and chin breakouts. It is not a first-line acne drug and is not typically used in men. This page lays out what the FDA label actually says, what the best evidence shows (the 2023 SAFA randomized trial and the 2024 American Academy of Dermatology guideline), how it is dosed, and the real risks.

Is this an FDA-approved use?

No — this is off-label. Off-label means a licensed physician is legally prescribing an FDA-approved drug for a condition not listed on its FDA label. It is common and legal in US medicine, but it means the FDA never formally reviewed spironolactone for acne. So the efficacy and safety evidence for acne comes from clinical trials, dermatology guidelines, and years of practice - not from an FDA approval - and the manufacturer is not allowed to market the drug for acne. FDA-approved: The FDA approved spironolactone (brand Aldactone) for high blood pressure (as add-on therapy), NYHA Class III-IV heart failure with reduced ejection fraction, edema from cirrhosis or nephrotic syndrome, primary hyperaldosteronism, and low potassium (hypokalemia). Acne is not an FDA-approved use - the word 'acne' does not appear anywhere on the FDA label.

By the pharmaranks editorial teamReviewed against the FDA drug label and specialty clinical guidelines sourcesUpdated Jul 20, 2026How we research

What the evidence actually shows

Spironolactone is an anti-androgen: it blocks dihydrotestosterone from binding androgen receptors on the skin's oil glands, reducing sebum (StatPearls) - the reason it targets hormonal acne. The strongest evidence is the 2023 SAFA trial (BMJ), a phase 3, double-blind, randomized study of more than 400 adult women: at 24 weeks, 82% of the spironolactone group reported improved acne versus 63% on placebo, with benefit greater at 24 weeks than at 12. The 2024 American Academy of Dermatology acne guideline gives spironolactone a 'conditional' recommendation - a lower tier than the 'strong' recommendations for benzoyl peroxide, topical retinoids, and doxycycline. Importantly, the evidence base is in women (adult, hormonal, often jawline and chin acne). It is not established or generally appropriate for men, because the same anti-androgen action causes breast tenderness and other feminizing effects in males.

How it's used off-label

Dosing is individualized by the prescriber. In dermatology, spironolactone for acne is commonly started around 50 mg/day and adjusted up to 100 mg/day, occasionally to 200 mg/day; the SAFA trial used 50 mg/day, increased to 100 mg/day at 6 weeks if tolerated. It works slowly - allow about 3 months to judge a response, with improvement often continuing toward 6 months. These figures are background information, not a dosing recommendation; only your prescriber can set a dose for you.

Risks and cautions

The main concern is hyperkalemia (high blood potassium), because spironolactone is potassium-sparing. Risk rises with kidney disease, older age, and other drugs that raise potassium - ACE inhibitors, ARBs, potassium supplements, and NSAIDs - and potassium-containing salt substitutes should be avoided (MedlinePlus). The 2024 AAD guideline says routine potassium testing is not needed in otherwise-healthy young women, but should be considered when risk factors are present. Other common effects: menstrual irregularities, breast tenderness or enlargement, and mild diuresis (more urination). Pregnancy: because it is an anti-androgen, spironolactone can theoretically interfere with development of a male fetus; the FDA label says to 'avoid spironolactone in pregnant women or advise a pregnant woman of the potential risk to a male fetus,' so it is typically used only with reliable contraception. On the tumor warning: spironolactone's labeling has historically carried an FDA boxed warning that it 'has been shown to be a tumorigen in chronic toxicity studies in rats.' The current FDA-approved brand (Aldactone) label no longer carries this boxed warning - the rat-tumor data now appears in the Nonclinical Toxicology section - but some generic spironolactone labels still display the original boxed warning. Those rat tumors occurred at doses far above human exposure, and large human studies have not found an increased risk of breast or other cancers.

What’s actually FDA-approved for acne (hormonal, in women)

FDA-approved acne treatments (unlike spironolactone) include: topical retinoids (adapalene, tretinoin, tazarotene, trifarotene); benzoyl peroxide; topical antibiotics such as clindamycin; topical clascoterone (Winlevi) - the first FDA-approved topical anti-androgen for acne (2020), usable in both women and men; oral antibiotics (doxycycline, minocycline, sarecycline); isotretinoin for severe or scarring acne; and several combined oral contraceptives FDA-approved for acne in women who also want birth control (e.g., Yaz, Beyaz, Ortho Tri-Cyclen, Estrostep). Many people use a topical plus one of these instead of, or alongside, spironolactone.

Bottom line

For adult women with persistent hormonal acne, spironolactone is a reasonable, well-studied off-label option - the SAFA trial and 2024 AAD guideline support it as an alternative to long courses of oral antibiotics - but it is not FDA-approved for acne, works slowly (about 3 months), and requires attention to potassium and pregnancy. It is not a men's acne drug. Discuss it with a dermatologist alongside FDA-approved options; only a prescriber can decide whether it fits your situation.

Frequently asked questions

Does spironolactone clear acne?

For many adult women with hormonal acne, yes. In the 2023 SAFA randomized trial, 82% of women on spironolactone reported improved acne at 24 weeks versus 63% on placebo. It reduces oil production by blocking androgens, so it works best on hormonal jawline and chin breakouts. It is off-label (not FDA-approved for acne) and is not typically effective or appropriate for men.

How long does spironolactone take to work for acne?

Slowly. Give it about 3 months before judging results; in the SAFA trial the benefit was larger at 24 weeks than at 12, so improvement often keeps building toward 6 months. It is not a quick fix, and prescribers usually pair it with a topical while you wait.

What is the spironolactone dosage for acne?

It is prescriber-decided and individualized. Dermatologists commonly start around 50 mg/day and adjust to 100 mg/day, occasionally up to 200 mg/day. The SAFA trial used 50 mg/day, raised to 100 mg/day at 6 weeks if tolerated. This is background information, not a dosing recommendation - only your prescriber can set your dose.

Can men take spironolactone for acne?

It is generally not used for acne in men. The same anti-androgen action that helps women causes unwanted effects in men - breast tenderness and enlargement (gynecomastia) and sexual side effects. Men with acne are usually offered other options, including topical clascoterone (Winlevi), which is FDA-approved for both sexes.

Do you need potassium blood tests on spironolactone?

Not always. The 2024 AAD guideline says routine potassium monitoring is not needed in otherwise-healthy young women taking it for acne. Testing is advised when risk factors for high potassium are present - kidney disease, older age, or interacting drugs such as ACE inhibitors, ARBs, or potassium supplements. Your prescriber decides based on your health.

Spironolactone vs birth control for acne - which is better?

They are different tools for the same hormonal driver, and are often used together. Certain combined oral contraceptives (e.g., Yaz, Ortho Tri-Cyclen) are FDA-approved for acne and also provide the reliable contraception that spironolactone's pregnancy caution calls for; spironolactone is off-label and anti-androgen. Neither is universally 'better' - many dermatologists combine them, and the choice depends on your health history and preferences.

Sources

More off-label uses: Trazodone for insomnia · Propranolol for anxiety · Gabapentin for anxiety · Metformin for PCOS · Amitriptyline for insomnia.

This is general reference information, not medical advice. Off-label prescribing is legal and common, but whether a drug is right for you — on-label or off — is a decision for you and a licensed prescriber. Do not start, stop or change a medication based on this page.